iRhythm Technologies, Inc. (IRTC)
NASDAQ: IRTC · Real-Time Price · USD
140.41
+0.63 (0.45%)
At close: May 14, 2025, 4:00 PM
138.38
-2.03 (-1.45%)
After-hours: May 14, 2025, 7:53 PM EDT
iRhythm Technologies Employees
iRhythm Technologies had 2,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$309,294
Profits / Employee
-$49,161
Market Cap
4.48B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IRTC News
- 12 days ago - Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts - Benzinga
- 13 days ago - iRhythm Technologies, Inc. (IRTC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection - GlobeNewsWire
- 15 days ago - iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference - GlobeNewsWire
- 16 days ago - iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring - GlobeNewsWire
- 27 days ago - iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025 - GlobeNewsWire
- 4 weeks ago - iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability - GlobeNewsWire
- 6 weeks ago - iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection - GlobeNewsWire